RT Journal Article SR Electronic T1 A VEGF-R2 Kinase Inhibitor Potentiates the Activity of the Conventional Chemotherapeutic Agents Paclitaxel and Doxorubicin in Tumor Xenograft Models JF Molecular Pharmacology JO Mol Pharmacol FD American Society for Pharmacology and Experimental Therapeutics DO 10.1124/mol.104.000638 A1 Stuart Emanuel A1 Robert H Gruninger A1 Angel Fuentes-Pesquera A1 Peter J Connolly A1 Jennifer A Seamon A1 Susan Hazel A1 Rose Tominovich A1 Beth Hollister A1 Cheryl Napier A1 Michael R D'Andrea A1 Michael Reuman A1 Gilles Bignan A1 Robert Tuman A1 Dana Johnson A1 Dave Moffatt A1 Mark Batchelor A1 Anne Foley A1 James O'Connell A1 Rodger Allen A1 Martin Perry A1 Linda Jolliffe A1 Steven A Middleton YR 2004 UL http://molpharm.aspetjournals.org/content/early/2004/06/10/mol.104.000638.abstract AB